These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29083322)

  • 21. Cyclin D2 is a critical mediator of exercise-induced cardiac hypertrophy.
    Luckey SW; Haines CD; Konhilas JP; Luczak ED; Messmer-Kratzsch A; Leinwand LA
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1820-1830. PubMed ID: 28901173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cadherin-11-Interleukin-6 Signaling between Cardiac Fibroblast and Cardiomyocyte Promotes Ventricular Remodeling in a Mouse Pressure Overload-Induced Heart Failure Model.
    Fang G; Li Y; Yuan J; Cao W; Song S; Chen L; Wang Y; Wang Q
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction.
    Fassett J; Xu X; Kwak D; Zhu G; Fassett EK; Zhang P; Wang H; Mayer B; Bache RJ; Chen Y
    J Mol Cell Cardiol; 2019 May; 130():49-58. PubMed ID: 30910669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy.
    Zhong B; Rubinstein J; Ma S; Wang DH
    Biomed Pharmacother; 2018 Mar; 99():261-270. PubMed ID: 29334670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosylphosphorylcholine alleviates pressure overload-induced myocardial remodeling in mice via inhibiting CaM-JNK/p38 signaling pathway.
    Ren FF; Zhao L; Jiang XY; Zhang JJ; Gou JM; Yu XY; Wu SJ; Li L
    Acta Pharmacol Sin; 2024 Feb; 45(2):312-326. PubMed ID: 37833535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling.
    Loyer X; Gómez AM; Milliez P; Fernandez-Velasco M; Vangheluwe P; Vinet L; Charue D; Vaudin E; Zhang W; Sainte-Marie Y; Robidel E; Marty I; Mayer B; Jaisser F; Mercadier JJ; Richard S; Shah AM; Bénitah JP; Samuel JL; Heymes C
    Circulation; 2008 Jun; 117(25):3187-98. PubMed ID: 18541744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload.
    Byun J; Del Re DP; Zhai P; Ikeda S; Shirakabe A; Mizushima W; Miyamoto S; Brown JH; Sadoshima J
    J Biol Chem; 2019 Mar; 294(10):3603-3617. PubMed ID: 30635403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.
    Dadson K; Turdi S; Hashemi S; Zhao J; Polidovitch N; Beca S; Backx PH; McDermott JC; Sweeney G
    J Mol Cell Cardiol; 2015 Sep; 86():102-9. PubMed ID: 26196305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
    Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
    J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
    Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Tanaka K; Sahara M; Hirata Y; Nagai R; Sata M
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):654-61. PubMed ID: 22116099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
    Pasumarthi KB; Nakajima H; Nakajima HO; Soonpaa MH; Field LJ
    Circ Res; 2005 Jan; 96(1):110-8. PubMed ID: 15576649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling.
    Shang L; Weng X; Wang D; Yue W; Mernaugh R; Amarnath V; Weir EK; Dudley SC; Xu Y; Hou M; Chen Y
    Free Radic Biol Med; 2019 Sep; 141():291-298. PubMed ID: 31254620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4.
    Yamamura S; Izumiya Y; Araki S; Nakamura T; Kimura Y; Hanatani S; Yamada T; Ishida T; Yamamoto M; Onoue Y; Arima Y; Yamamoto E; Sunagawa Y; Yoshizawa T; Nakagata N; Bober E; Braun T; Sakamoto K; Kaikita K; Morimoto T; Yamagata K; Tsujita K
    Hypertension; 2020 Jan; 75(1):98-108. PubMed ID: 31735083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice.
    Zou Y; Li J; Ma H; Jiang H; Yuan J; Gong H; Liang Y; Guan A; Wu J; Li L; Zhou N; Niu Y; Sun A; Nakai A; Wang P; Takano H; Komuro I; Ge J
    J Mol Cell Cardiol; 2011 Nov; 51(5):821-9. PubMed ID: 21854784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and postcapillary pulmonary hypertension in mice.
    Sunamura S; Satoh K; Kurosawa R; Ohtsuki T; Kikuchi N; Elias-Al-Mamun M; Shimizu T; Ikeda S; Suzuki K; Satoh T; Omura J; Nogi M; Numano K; Siddique MAH; Miyata S; Miura M; Shimokawa H
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7129-E7138. PubMed ID: 29987023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure.
    Funayama A; Shishido T; Netsu S; Narumi T; Kadowaki S; Takahashi H; Miyamoto T; Watanabe T; Woo CH; Abe J; Kuwahara K; Nakao K; Takeishi Y; Kubota I
    Cardiovasc Res; 2013 Sep; 99(4):657-64. PubMed ID: 23708738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.
    Lauriol J; Keith K; Jaffré F; Couvillon A; Saci A; Goonasekera SA; McCarthy JR; Kessinger CW; Wang J; Ke Q; Kang PM; Molkentin JD; Carpenter C; Kontaridis MI
    Sci Signal; 2014 Oct; 7(348):ra100. PubMed ID: 25336613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plin5 deficiency exacerbates pressure overload-induced cardiac hypertrophy and heart failure by enhancing myocardial fatty acid oxidation and oxidative stress.
    Wang C; Yuan Y; Wu J; Zhao Y; Gao X; Chen Y; Sun C; Xiao L; Zheng P; Hu P; Li Z; Wang Z; Ye J; Zhang L
    Free Radic Biol Med; 2019 Sep; 141():372-382. PubMed ID: 31291602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.